Skip to main content

Table 6 Expression of Smad4 in lung cancer tissues (N = 52)

From: Correlation between loss of Smad4 and clinical parameters of non-small cell lung cancer: an observational cohort study

Parameter

Group

N

Expression of Smad4

Negative (%)

Positive (%)

χ2 value

P value

Specimen source

Normal

52

14 (26.9)

38 (73.1)

5.798

0.009

Cancerous

52

27 (51.9)

25 (48.1)

  

Gender

Male

31

15 (48.4)

16 (51.6)

0.384

0.535

Female

21

12 (57.1)

9 (42.9)

  

Ages

 < 60

29

15 (51.7)

14 (48.3)

0.001

0.974

 ≥ 60

23

12 (52.2)

11 (47.8)

  

Smoking

No

27

13 (48.1)

14 (51.9)

0.321

0.571

Yes

25

14 (56)

11 (44)

  

Histology

LAC

19

12 (63.2)

7 (36.8)

1.514

0.219

LSCC

33

15 (45.5)

18 (54.5)

  

Pathological grade

Poorly

11

10 (90.9)

1 (9.1)

10.264

0.006

Moderately

19

10 (52.6)

9 (47.4)

  

Well

22

7 (31.8)

15 (68.2)*

  

Lymph node metastasis

N0–N1

37

15 (40.5)

22 (59.5)

6.657

0.010

N2–N3

15

12 (80)

3 (20)

  

TNM

IB-IIB

29

8 (27.6)

21 (72.4)

15.55

< 0.001

IIIA

23

19 (82.6)

4 (17.4)

  
  1. N numbers of patients, LAC lung adenocarcinoma, LSCC lung squamous cell carcinoma, TNM the TNM Classification of Malignant Tumours
  2. *p < 0.05, well differentiated tissues compared with poorly differentiated tissues